KATHERINE GRESHAM: Open Payments
NPI 1225652720 · JACKSBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,551 in 152 payments from 26 companies in 2025. Trend: 2023 $3,026 · 2024 $3,039 · 2025 $2,551
Food & beverage: $2,551
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $561 |
| Axsome Therapeutics, Inc. | 16 | $253 |
| PFIZER INC. | 19 | $217 |
| Lundbeck LLC | 10 | $199 |
| Otsuka America Pharmaceutical, Inc. | 11 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| Lilly USA, LLC | 8 | $112 |
| GlaxoSmithKline, LLC. | 7 | $107 |
| Esperion Therapeutics, Inc. | 5 | $98 |
| Phathom Pharmaceuticals, Inc. | 4 | $78 |
Products named: REXULTI, VRAYLAR, CREON, NURTEC ODT, QULIPTA, UBRELVY, Sunosi, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
